检索结果-南通市图书馆

SARS-CoV-2 infection rates after different vaccination schemes:An online survey in Turkey

Asian Pacific Journal of Tropical Medicine 2022年第4期15卷 171-178页

作者： Oya Baydar Toprak sennur ozen Berker Ozturk Burcu Ozturk Ebru Ozturk Mehmet Kitapci Nurdan Kokturk Chest Diseases Department Faculty of MedicineCukurova UniversityAdanaTurkey Department of Pulmonary Medicine Delta HospitalIstanbulTurkey Chest Diseases Department Aksaray Training and Research HospitalAksarayTurkey Department of Pulmonary Medicine Faculty of MedicineGazi UniversityAnkaraTurkey Department of Biostatistics Hacettepe UniversityAnkaraTurkey Department of Nuclear Medicine Integra Medical Imaging CenterAnkaraTurkey

Objective:To identify effects of various nationwide vaccination protocols on the evolution of new SARS-CoV-2 infections among adult population and to evaluate the safety of mRNA(BioNTech/Pfizer)***:Totally 10735 adult volunteers that received at least one dose of BioNTech/Pfizer or triple doses of CoronaVac participated in this cross-sectional-online survey between 1 and 10 September *** information was collected covering a 5-month period from April 2021 to September *** about people who were vaccinated with only single and double dose CoronaVac were not included in this ***:At least one side effect after single and double dose of BioNTech/Pfizer and triple doses of CoronaVac were observed in 42.1%,42.5%and 10.9%,*** most common side effects were shoulder/arm pain,weakness/fatigue,muscle/joint pain and *** side effects were the most frequent in single BioNTech/Pfizer,while it was the least in triple *** rate of positive PCR tests before vaccination was 17.6%,and decreased to 3.0%after *** rates of positive SARS CoV-2-PCR were 18.8%,3.5%,3.1%,0.5%and 4.6%in single BioNTech/Pfizer,double BioNTech/Pfizer,double CoronaVac+single BioNTech/Pfizer,double CoronaVac+double BioNTech/Pfizer and triple CoronaVac,*** 1.8%of PCR positive COVID-19 cases needed intensive unit care in the pre-vaccination period,intensive care unit was required in 0%,1.5%,2.4%,0%and 4.2%after single BioNTech/Pfizer,double BioNTech/Pfizer,double CoronaVac+single BioNTech/Pfizer,double CoronaVac+double BioNTech/Pfizer and triple CoronaVac,*** rate after vaccination was 0.4%.Conclusions:The rarity of COVID-19 infection after vaccination suggests that efficacy of vaccines is *** the other hand,the data underscore the critical importance of continued public health mitigation.

关键词： mRNA vaccine COVID-19 SARS-CoV-2 Vaccine schemes Reinfection Positivity rate after vaccination

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：